ATEK vs. CRTX, OMCL, HSTM, MDRX, JMAC, ENPC, AXAC, DHHC, EVE, and PRPB
Should you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), Maxpro Capital Acquisition (JMAC), Executive Network Partnering (ENPC), AXIOS Sustainable Growth Acquisition (AXAC), DiamondHead (DHHC), EVe Mobility Acquisition (EVE), and CC Neuberger Principal Holdings II (PRPB).
Athena Technology Acquisition vs. Its Competitors
Cortexyme (NASDAQ:CRTX) and Athena Technology Acquisition (NYSE:ATEK) are both small-cap health care technology companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.
In the previous week, Cortexyme had 2 more articles in the media than Athena Technology Acquisition. MarketBeat recorded 2 mentions for Cortexyme and 0 mentions for Athena Technology Acquisition. Athena Technology Acquisition's average media sentiment score of 0.34 beat Cortexyme's score of 0.00 indicating that Athena Technology Acquisition is being referred to more favorably in the news media.
Cortexyme has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500. Comparatively, Athena Technology Acquisition has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500.
Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.
63.2% of Cortexyme shares are owned by institutional investors. Comparatively, 17.3% of Athena Technology Acquisition shares are owned by institutional investors. 27.9% of Cortexyme shares are owned by company insiders. Comparatively, 88.4% of Athena Technology Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Athena Technology Acquisition beats Cortexyme on 4 of the 7 factors compared between the two stocks.
Get Athena Technology Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Athena Technology Acquisition Competitors List
Related Companies and Tools
This page (NYSE:ATEK) was last updated on 10/10/2025 by MarketBeat.com Staff
